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According to the WHO, in 2008 cardiovascular diseases claimed the lives of 17.5 million people (30 % of all
diseases). Often the only option to save a patient’s life is a replacing the injured part of an organ by the prosthe-
sis. Aim. This research was aimed to produce biomodificated cardiovascular graft by decellularisation of por-
cine heart valve. Methods. Our method of decellularization permits to make morphologically and physically
non-modified decellularised extracellular matrix. Results. The analysis of matrix shows a decrease of the total
number of cells, preservation of the collagen and elastin fibers structure, and safety of physiological adhesion.
Conclusions. The matrix can be used as a framework for the vessel-valvular tissue-engineering prosthesis after
its recellularization by the recipient’s autologous cells.
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Introduction. Each year, cardiovascular diseases claim
the lives of millions of people, and are the prevailing
cause of death for last two decades. Often the only op-
tion to save a patient’s life is a replacing the injured part of
an organ by the prosthesis. Annually in the world about
275,000 of such surgeries have been performed. Surgical
replacement by either mechanical or bioprosthetic heart
valves is the most common treatment for the end-stage
valvular diseases [1, 2].
Mechanical valves display good structural durabili-
ty but are associated with some problems for recipients.
The mechanical prostheses are unable to provide full
adaptation to physiological environment such as the
pressure change and strength characteristics, since the
non-living materials are used for their production [3].
For the same reason, they are not capable of growth and
development in the body, which makes them unsuitable
in pediatric cardiac surgery. Furthermore, the use of me-
chanical prostheses can cause the thromboembolic di-
sease which needs lifelong anticoagulant therapy [4–6].
Bioprosthetic heart valve replacements are either of
animal origin (xenografts), such as porcine aortic val-
ves and bovine pericardial valves, or taken from human
donors (homografts). Usage of xenografts makes it pos-
sible to have the valves of different sizes stored and
available off-the-shelf. Moreover they enable to avoid
anticoagulative therapy and have a potential of remode-
ling in recipient’s organism [7]. Several attempts have
been made to create functional heart valve replacements
able to grow as a patient grows older, to be repaired and
remodeled. With the approach of tissue engineering, the
patient’s own cells are isolated, e. g. from a bone mar-
row, and seeded onto prepared matrices, in the three-di-
mensional structure (for example, extracellular matrix
(ECM) of xenografts previously decellularized) [4].
All tissues and organs are made up of cells and an
associated extracellular matrix – a secreted product of
the resident cells consisting of a unique, tissue-specific
three-dimensional environment of structural and func-
tional molecules. They are usually regarded as cells with
a supporting stroma.
So, the success in creating viable autologous cardio-
vascular graft depends on three main elements: autolo-
gous cells suitable phenotypically and functionally; a
matrix as a temporary scaffold that gives the tissue
strength as long as the new extracellular matrix with
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autologous cells is being synthesized; the tissue forma-
tion and development under the in vitro conditions clo-
se to the physiological ones [3].
The extracellular matrix is viewed in terms of its ro-
le in structural maintenance and three-dimensional sha-
pe of the respective tissue or organ. However, the extra-
cellular matrix is the microenvironmental niche, and it
is in the dynamic reciprocity with the resident cell po-
pulation. That is why the phenotype of the resident cells,
including their active genetic profile, proteome, and
functionality, is influenced by the conditions of their
microenvironmental niche. Thus, the native extracellu-
lar matrix is a logical and ideal scaffold for the organ
and tissue reconstruction.
Moreover, structural and functional molecules in the
extracellular matrix (glycosaminoglycans, collagen, ela-
stin, fibronectin, laminin, and vitronectin) are highly
conserved proteins in eukaryotic organisms, which lar-
gely explains the absence of an adverse immune respon-
se after xenotransplantation [8].
There are evidences that grafts failure, at least in
part, is a result of immunological reactions, caused by
cellular elements remaining in the homograft’s matrix,
that trigger the immune reaction by the receiver. The en-
dothelial cells and fibroblasts are able to express Class I
and II histocompatibility complex that are recognized
by the receiver’s immune system and can be a cause of
tissue degeneration and graft failure [9].
The decellularization of xenogeneic matrices is a
possibility to prevent the graft failure induced by the im-
mune response. Moreover, it is a chance to create a pati-
ent specific viable heart valve with tissue engineering
(TE) techniques. There are the studies suggesting that
decellularized heterografts lead to a reduced inflam-
matory response of the receiver and are able to be pro-
gressively repopulated by the autologous cells [9].
The main purpose of decellularization is to remove
all cellular components, by maintaining intact the struc-
tural elements of the extracellular matrix. Of today, se-
veral methods of the pre-transplant treatment of trans-
plants have been developed. They provide a donor cell
death without using crosslinking agents, and a subsequ-
ent colonization of the recipient cells prior to implanta-
tion [10].
Of now, a variety of tissue decellularization methods
have been developed in the world. All of them can be
assembled into two main groups: methods, suggesting
the use of substances that cause necrosis; and methods
allowing decellularization by inducing apoptotic cell
death. Both groups have their pros and cons [10–15].
The method of decellularization with the calcium-
free solution of ethylenediaminetetraacetic acid (EDTA)
belongs to the apoptosis-inducing methods. EDTA is a
chelate, which is able to bind calcium ions, so that the in-
teraction between cadherins becomes broken, which re-
sults in cells dissociation. At the same time, according
to the published data, it is possible that EDTA in high
concentration initiates the apoptosis processes [12, 15].
However, it should be noted that the method of de-
cellularization with the EDTA does not allow achie-
ving a complete removal of dead cells from the depth of
the matrix. Perhaps, this is due to the fact that cells can
migrate from the surface of the tissue to its depth be-
cause of the negative chemotaxis. On the other hand, it
is common knowledge that apoptosis can be realized
till the end in vivo with macrophages [15].
The aim of research is to assess the effective con-
ditions of apoptosis-inducing decellularization of xeno-
geneic valves, and to evaluate the integrity and physio-
logical intactness of the obtained extracellular matrix
during decellularization of heart valves.
Materials and methods. The research was perfor-
med with cardiac valves of 6-month-old pigs (n = 7).
Heart sampling was carried out in the operating room
conditions in accordance with the requirements of Eu-
ropean Convention for the Protection of Vertebrate Ani-
mals Used for Experimental and Other Scientific Pur-
poses (Strasbourg, 1986) and the statements of the 1
st
National Congress on Bioethics (Kyiv, 2001). The val-
ves were derived under sterile conditions on the avera-
ge four hours after heart sampling. The obtained samp-
les were exposed in apoptosis-inducing solution of 10
mM EDTA («Sigma», USA) for two days. After expo-
sure the samples were carefully washed in the medium
with salts of concentration close to physiological one.
Such kind of decellularization by inducing apopto-
sis was firstly proposed by Akatov and his colleagues –
Russian scientists of Bakoulev Scientific Center for
Cardiovascular Surgery [16]. In spite of advantages of
the apoptosis-inducing method of decellularisation, the-
re are some complexities in it. Therefore, the authors of-
fered to use DMEM as a solvent for EDTA.
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We supposed that the medium Eagle MEM without
Ca2+ is a better solvent for EDTA as a chelate of calci-
um ions. Due to the usage of this modification of me-
dium we could reduce the washing time after decellula-
risation solution to two days. Moreover, we permanent-
ly mixed up the medium with the decellularised graft
by roller, which helps us to increase the efficiency of de-
cellularisation. Our modification of the Akatov’s decel-
lularisation method, is protected by the Ukrainian pa-
tent N 85240.
To examine the efficiency of apoptosis initiation, the
tissue integrity and cell removing samples were analyzed
histologically. Slices of each conduit were embedded
in paraffin. For general morphology, three sections (5
m) of each slice were stained with hematoxylin and eo-
sin [17]; underwent special staining (Apoptag® Peroxi-
dase ISOL Kit, «Chemicon», USA) [www. millipore.
com/catalogue/item/s7200] to allow the identification of
breaks in DNA at initial stages of apoptosis [18]; and
stained according to Verhoeff to evaluate the state of
elastic and collagen fibers for assessment of safety of
extracellular matrix strength and flexibility [17].
To assess adhesive properties of matrix the decellu-
larized grafts were incubated with human fetal fibro-
blasts derived and cultured according to the standard
method [19]. Before incubation the culture of fibro-
blasts was stained with vital fluorescent dye PKH 67
Green («Sigma») and resuspended in cultural medium.
The adhesion rate of decellularized tissue of cardiac val-
ves was estimated by the fifth day of incubation using
fluorescent microscopy.
Results and discussion. Specimens of decellulari-
zed porcine matrix were not cell-free in the leaflets and
the conduit wall. Histological analysis revealed just a
decrease in the total number of cells, appearance of pro-
nounced changes in nuclei morphology in most of them
(karyopyknosis, karyorhexis) testifying to the success-
ful initiation of apoptosis (Fig. 1, A). The cells of control
(intact) samples on the contrary had normal morphologi-
cal characteristic for fibroblasts: extended spindlesha-
ped cells with oval shaped nucleus (Fig. 1,B) [20, 21].
Specific staining with Apoptag® peroxidase showed
different content of cells at the apoptosis state in various
structures of valve (Fig. 2). The highest number of the
apoptotic cells was found in the leaflet. This may be as-
sociated with its relative thinness if compared with the
vessel wall or the annulus fibrosis region that could
simplify the penetration of treating solution deep into the
structure and following apoptosis induction. Additio-
nally, a larger number of viable cells in tissue depth, if
compared with superficial zones in regions with comp-
licated structure, is also associated with the cell migra-
tion due to the negative chemotaxis [21, 22].
Histological analysis of the sections after specific
staining for extracellular matrix showed good preserva-
tion of the matrix architecture [23, 24], the structure and
orientation of collagen and elastin fibers after decellula-
rization are safe. The staining of extracellular matrix fi-
bers according Verhoeff was successful in both aorta
wall area (maroon color) and valve leaflet area (crimson
color) (Fig. 3).
A fluorescent analysis of supposed transplants revea-
led the bright fluorescencing cells adhered to connective
tissue matrix under violet blue excitation, which shows
the preservation of adhesive properties of the extracellu-
lar matrix and its availability for further colonization
with tissue-forming autologous cells of the recipient.
The present study provides evidence of a successful
in vitro producing of tissue engineered grafts, fits for the
reconstruction of heart valve. The described method of
tissue engineering is based on decellularization of por-
cine heart valves by inducing apoptotic cell death with
the calcium-free solution with EDTA. According to the
obtained data we may suggest that EDTA solution of 10
mM as well as the proposed scheme of grafts treat-
ment are effective in terms of decellularization. As we
expected this type of tissue treatment induces apoptotic
cell death in the donor grafts, total number of cells de-
creases, the changes in nuclei morphology (karyopyk-
nosis, karyorhexis) in most part of remaining cells ap-
pear, but the total decellularization of tissue is not rea-
ched in vitro. The initiation of apoptosis in valve leaflet
as well as on the surface of the valve vascular region was
efficient. The initiation of apoptosis was not uniform in
different structures of xenograft.
Conclusions. Positive specific staining of extracel-
lular matrix and results of its fluorescent analysis allow-
ed a suggestion that the matrix saves its physiological
integrity after decellularization. After treatment with
decellularizing solution, the connective tissue matrix of
grafts preserved its morphofunctional and adhesive pro-
perties. Therefore it would be suitable for further colo-
288
SAVCHUK M. V.
289
TISSUE ENGINEERING OF VASCULAR/VALVULAR EQUIVALENTS ON THE BASE OF THE XENOGENEIC MATRIX
A B
Fig. 1. Results of hematoxylin and
eosin staining (light microscope,
magnification  400): A – speci-
mens after decellularization (thin
arrow – karyopyknosis; thick ar-
row – karyorhexis); B – control
(intact) samples
Fig. 2. Specific staining with Apoptag® Peroxidase ISOL Kit
(«Che- micon»). Magnification  225. Thin arrow – alive blue
colored cells; thick arrow – apoptotic brown colored cells
A B
C
Fig. 3. Result of extracellular matrix staining according to
Verhoeff; light microscope, magnification 30:A – specimens
after decellularization; B – normal aorta wall;C – normal valve
leaflet
nization by autologous recipient cells (to realize the re-
vitalization) and use as a tissue-engineered cardiovascu-
lar prosthesis.
Òêàíèííî-³íæåíåðíèé ñóäèííî-êëàïàííèé åêâ³âàëåíò íà îñíîâ³
êñåíîãåííîãî äåöåëþëüîâàíîãî ìàòðèêñó
Ì. Â. Ñàâ÷óê
Ðåçþìå
Çã³äíî ç äàíèìè ÂÎÎÇ, ó 2008 ðîö³ â ñâ³ò³ â³ä ñåðöåâî-ñóäèííèõ çà-
õâîðþâàíü ïîìåðëî 17,5 ìëí ëþäåé (30 % óñ³õ çàõâîðþâàíü). ×àñ-
òî ºäèíî ìîæëèâèì âàð³àíòîì ñïàñ³ííÿ æèòòÿ ïàö³ºíòà º çàì³-
íà ïîøêîäæåíî¿ ä³ëÿíêè îðãàíà ïðîòåçîì.Ìåòà. Îòðèìàííÿ á³î-
ìîäèô³êîâàíîãî ñåðäöåâî-ñóäèííîãî ãðàôòà çà ðàõóíîê äåöåëþëÿ-
ðèçàö³¿ ñåðöåâîãî êëàïàíà ñâèí³. Ìåòîäè. Òåõíîëîã³ÿ îäåðæàííÿ
ìîðôîëîã³÷íî ³ ô³çè÷íî íå çì³íåíîãî äåöåëþëÿðèçîâàíèé åêñòðà-
öåëþëÿðíîãî ìàòðèêñó. Ðåçóëüòàòè. Àíàë³ç ìàòðèêñó äåìîíñò-
ðóº çíèæåííÿ çàãàëüíî¿ ê³ëüêîñò³ êë³òèí, çáåðåæå- í³ñòü ñòðóêòó-
ðè êîëàãåíîâèõ òà åëàñòèíîâèõ âîëîêîí, à òàêîæ ô³ç³îëîã³÷íî¿
àäãåçèâíîñò³ ìàòðèêñó. Âèñíîâêè. Ìàòðèêñ ï³ñëÿ äåöåëþëÿðè-
çàö³¿ º ïðèäàòíèì äëÿ âèêîðèñòàííÿ ÿê êàðêàñà äëÿ ñóäèííî-êëà-
ïàííîãî òêàíèííî-³íæåíåðíîãî ïðîòåçó ï³ñëÿ éîãî ðåöåëþëÿðè-
çàö³¿ àóòîëîã³÷íèìè êë³òèíàìè ðåöèï³ºíòà.
Êëþ÷îâ³ ñëîâà: òêàíèííà ³íæåíåð³ÿ, åêñòðàöåëþëÿðíèé
ìàòðèêñ, äåöåëþëÿðèçàö³ÿ.
Òêàíåèíæåíåðíûé ñîñóäèñòî-êëàïàííûé ýêâèâàëåíò íà îñíîâå
êñåíîãåííîãî äåöåëëþëèðîâàííîãî ìàòðèêñà
Ì. Â. Ñàâ÷óê
Ðåçþìå
Ñîãëàñíî äàííûì ÂÎÇ, â 2008 ãîäó â ìèðå îò ñåðäå÷íî-ñîñóäèñ-
òûõ çàáîëåâàíèé óìåðëè 17,5 ìëí ÷åëîâåê (30% âñåõ çàáîëåâàíèé).
×àñòî åäèíñòâåííî âîçìîæíûì âàðèàíòîì ñïàñåíèÿ æèçíè ïà-
öèåíòà ÿâëÿåòñÿ çàìåíà ïîâðåæäåííîãî ó÷àñòêà îðãàíà ïðîòå-
çîì. Öåëü. Ïîëó÷åíèå áèîìîäèôèöèðîâàííîãî ñåðäå÷íî-ñîñóäèñ-
òîãî ãðàôòà âñëåäñòâèå äåöåëëþëèðîâàíèÿ ñâèíîãî ñåðäå÷íîãî
êëàïàíà.Ìåòîäû. Íàøà òåõíîëîãèÿ ïîçâîëÿåò ïîëó÷èòü ìîðôî-
ëîãè÷åñêè è ôèçè÷åñêè íå èçìåíåííûé äåöåëëþëèðîâàííûé ýêñòðà-
öåëëþëÿðíûé ìàòðèêñ. Ðåçóëüòàòû. Àíàëèç ìàòðèêñà äåìîíñò-
ðèðóåò ñíèæåíèå îáùåãî êîëè÷åñòâà êëåòîê, ñîõðàííîñòü ñòðóê-
òóðû êîëëàãåíîâûõ è ýëàñòèíîâûõ âîëîêîí, à òàêæå ôèçèîëîãè-
÷åñêîé àäãåçèâíîñòè ìàòðèêñà. Âûâîäû. Òàêèì îáðàçîì, ìàò-
ðèêñ ÿâëÿåòñÿ ïðèãîäíûì äëÿ èñïîëüçîâàíèÿ åãî â êà÷åñòâå êàð-
êàñà ñîñóäèñòî-êëàïàííîãî òêàíå-èíæåíåðíîãî ïðîòåçà ïîñëå
ðåöåëëþëÿðèçàöèè àóòîëîãè÷íûìè êëåòêàìè ðåöèïèåíòà.
Êëþ÷åâûå ñëîâà: òêàíåâàÿ èíæåíåðèÿ, ýêñòðàöåëëþëÿðíûé
ìàòðèêñ, äåöåëëþëÿðèçàöèÿ.
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